DNA RNA and Cells

21 Dec 2009 Teva Expands Innovative Pipeline with License Agreement to Develop and Commercialize OncoGenex' Late Stage Innovative Treatment for Multiple Oncology Indications
18 Dec 2009 European Medicines Agency recommendation on Cerepro
18 Dec 2009 Neuralstem Receives Approval To Commence First ALS Stem Cell Trial at Emory ALS Center
18 Dec 2009 SINGLE DOSE OF PROPRIETARY ADULT STEM CELLS REGENERATES DAMAGED PANCREAS AND REDUCES BLOOD GLUCOSE LEVELS IN DIABETES
16 Dec 2009 AS1411 shows activity in kidney cancer but AML remains priority
11 Dec 2009 iCo Therapeutics Provides Phase 1 Diabetic Macular Edema (DME) Clinical Trial Update and Phase 2 Trial Guidance
10 Dec 2009 UT Houston Researchers Launch Phase II Trial of Stem Cells and Acute Heart Attack
10 Dec 2009 Successful Stem Cell Therapy for Treatment of Eye Disease
10 Dec 2009 FDA Grants Cequent IND – Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology
09 Dec 2009 MOLOGEN applies for phase 2 clinical study for cancer drug MGN 1703
09 Dec 2009 Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium
07 Dec 2009 Gentium Announces Final Clinical Trial Results for Defibrotide Presented at the American Society of Hematology Conference
04 Dec 2009 InVivo Therapeutics Corporation Files FDA Application for Human Studies for Spinal Cord Injury Treatment
03 Dec 2009 Neurologix Completes All Surgical Procedures in Its Clinical Trial for Parkinson's Disease
03 Dec 2009 Isis Pharmaceuticals Adds Two New Drugs to Development Pipeline
03 Dec 2009 MDRNA, Inc. Presents Positive Efficacy and Tolerability Data in Non-Human Primates With Proprietary siRNA Compounds
03 Dec 2009 New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C
01 Dec 2009 Pluristem Therapeutics Completes Dosing of First Group of Patients in Europe With Placenta-Derived Cell Therapy Product PLX-PAD in Phase I Clinical Trial for Treatment of Critical Limb Ischemia (CLI)
01 Dec 2009 Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia
30 Nov 2009 Lorus Therapeutics Announces Positive Result in Its Phase II Clinical Study of LOR-2040 in Acute Myeloid Leukemia (AML)
30 Nov 2009 Kiadis Pharma announces enrollment of first patients in a multinational registration study for ATIR
25 Nov 2009 Idera Pharmaceuticals Announces Termination of Asthma and Allergy Research Collaboration Agreement
25 Nov 2009 Idera Pharmaceuticals and Merck & Co., Inc. Extend Research Collaboration for Agonists of Toll-like Receptors as Vaccine Adjuvants
24 Nov 2009 MDRNA Expands RNAi Bladder Cancer Program With the Vancouver Prostate Centre
23 Nov 2009 BioAlliance Pharma presents efficacy and safety preclinical results for its AMEP™ anti-invasive biotherapy at the ESGCT Annual Congress in Hannover, November 21 to 25, 2009

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top